Replies to post #1728 on Vitro Diagnostics Inc (fka VODG)

[Potse]

rocketeer357...customer revenue, OSU, Junzhi Li, etc.....

So how much product did that impressed customer buy?

I have no idea how much product a specific VODG/Neuromics customer may have purchased. But in the absence of that information it is still interesting to monitor the people/companies that seem to be taking more notice of VODG and/or its products. Some of the interest that is being generated may ultimately lead to increased levels of business activity down the road, either in the form of direct revenue production or perhaps open the doors to potential joint ventures or merger/acquisition activity.

Getting James Posillico to take on all the expenses/time required to commercialize Vitropin is a fairly nice endorsement of VODG's fertility-related technology. The quality of the MSC-Gro product line basically gets a pretty nice endorsement when someone like Junzhi Li (StemGenesis CEO, background includes Harvard professor, Chief Research Scientist at ThermoGenesis -- NASDAQ: KOOL, co-inventor on a number of US patents) enters into an agreement with VODG for the distribution of MSC-Gro into China.

It looks like MSC-Gro may have been used in some pancreatic cancer research conducted by Ohio State University. It started showing up on Google hits in late March or early April. The full text of the research project is not freely available so I'm not able to confirm that, or see if any of VODG's stem cells were also used......

http://cancerres.aacrjournals.org/content/early/2013/03/20/0008-5472.CAN-12-4601.abstract

Neuromics CEO Pete Shuster made the following comment April 13 on Facebook following his first VODG board meeting.....

Attended my first meeting as a Vitro Biopharma board member in Winter Park, Co. What and inspiring location and team. We will have many new Stem Cell Related Product Announcements in the coming months: http://vitrobiopharma.com/

https://www.facebook.com/neuromics1